Fluorescence quenching-based immunological probe for ticagrelor monitoring

Fluorescence quenching-based immunological probe for ticagrelor monitoring

Introduction: Ticagrelor is extensively utilized for the treatment of acute coronary syndromes (ACS), but its platelet aggregation inhibitory effects can potentially result in tissue bleeding, posing a serious risk to patients’ lives.Methods: In this study, we developed highly sensitive full length...

Full description

Bibliographic Details
Main Authors:	Shengshuo Zhang, Yueqing Cheng, Yujie Gao, Yujie Zou, Weiling Xiao, Tianyi Li, Mei Li, Bowen Yu, Jinhua Dong
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-11-01
Series:	Frontiers in Bioengineering and Biotechnology
Subjects:	ticagrelor acute coronary syndrome Q-body immunofluorescence sensor rapid detection full-length IgG
Online Access:	https://www.frontiersin.org/articles/10.3389/fbioe.2023.1295406/full

Similar Items

Seroprevalencia de Toxoplasma gondii en donantes de sangre en la provincia de Guantánamo Seroprevalence of Toxoplasma gondii in blood donors from the province of Guantánamo
by: Rolando Sánchez Artigas, et al.
Published: (2012-03-01)

IgG/IgA pemphigus with differing regional presentations
by: Hok Fai Cheng, MBBS(HK), MRCP(UK), FHKAM(Medicine), et al.
Published: (2022-10-01)

Absolute thrombocytopenia with ticagrelor
by: Awatif Hafiz, et al.
Published: (2024-01-01)

Contributions of UDP-Glucuronosyltransferases to Human Hepatic and Intestinal Metabolism of Ticagrelor and Inhibition of UGTs and Cytochrome P450 Enzymes by Ticagrelor and its Glucuronidated Metabolite
by: Shuaibing Liu, et al.
Published: (2021-10-01)

The Role of Ticagrelor in STEMI Fibrinolytic and Its Rationale to Utilize for Indonesian Patients
by: Daniel Tobing, et al.
Published: (2019-09-01)

Ticagrelor
by: Gianluca Airoldi, et al.
Published: (2013-03-01)

An interesting case series of ticagrelor induced long QTc
by: Alireza Farzaei, et al.
Published: (2024-09-01)

Reacción de hipersensibilidad a ticagrelor
by: Jorge Alberto Castro Clavijo, et al.
Published: (2020-02-01)

Factors Determining Ticagrelor-Induced Dyspnea in Patients with Acute Coronary Syndrome
by: Vytenis Tamakauskas, et al.
Published: (2022-10-01)

Lymphocytic Choriomeningitis Virus Infections and Seroprevalence, Southern Iraq
by: Hussein Alburkat, et al.
Published: (2020-12-01)

A Case Report of Ticagrelor-Induced Thrombocytopenia
by: Alsalman M
Published: (2023-07-01)

The Effect of Platelet Activity, ABCB1 Genetic Polymorphism, and Renal Function on the Development of Ticagrelor-Related Dyspnea in Patients with Acute Coronary Syndrome
by: Tamakauskas V, et al.
Published: (2024-01-01)

Compared efficacy of clopidogrel and ticagrelor in treating acute coronary syndrome: a meta-analysis
by: Dong Wang, et al.
Published: (2018-11-01)

Comparison on the performance of Leishmania major-like and Leishmania braziliensis braziliensis as antigen for new world leishmaniasis IgG-immunofluorescence test Comparação do desempenho de antígenos de Leishmania major-like e Leishmania braziliensis braziliensis no teste de imunofluorescência-IgG para leishmaniose mucocutânea
by: Maria Carolina Soares Guimarães, et al.
Published: (1991-12-01)

Ticagrelor Use in Stroke Patients: Past, Present, and Future
by: Chandra R, et al.
Published: (2021-06-01)

Pharmacokinetics, Bioequivalence and Safety Evaluation of Two Ticagrelor Tablets Under Fasting and Fed Conditions in Healthy Chinese Subjects
by: Wang J, et al.
Published: (2021-03-01)

INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION
by: E. V. Tavlueva, et al.
Published: (2017-11-01)

Role of ticagrelor in the peri-thrombolytic phase for patients with ST-segment elevation myocardial infarction: a comprehensive review
by: Junyan Zhang, et al.
Published: (2024-10-01)

CHANGES IN THE IMMUNOLOGIC MARKERS OF ELASTIN DEGRADATION IN SUBJECTS WITH METABOLIC SYNDROME
by: Edward Mekenyan, et al.
Published: (2012-12-01)

Impact of Crystal Habit on Solubility of Ticagrelor
by: Yan Ren, et al.
Published: (2019-10-01)

Teofilina para o Alívio da Dispneia Relacionada ao Ticagrelor
by: Marcelo Sanmartin-Fernandez, et al.
Published: (2021-07-01)

Ticagrelor versus clopidogrel in the management of acute myocardial infarction
by: Candice Volney, et al.
Published: (2019-07-01)

Effectiveness of <i>Strongyloides</i> Recombinant IgG Immunoreactive Antigen in Detecting IgG and IgG4 Subclass Antibodies for Diagnosis of Human Strongyloidiasis Using Rapid Immunochromatographic Tests
by: Patcharaporn Boonroumkaew, et al.
Published: (2020-08-01)

Clinical outcomes with the use of ticagrelor or clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction – A prospective observational study
by: Bibek Agarwal, et al.
Published: (2022-01-01)

Anti-VP1 and anti-VP2 antibodies detected by immunofluorescence assays in patients with acute human parvovirus B19 infection
by: Renata FA Pereira, et al.
Published: (2001-05-01)

CHANGES IN THE IMMUNOLOGIC MARKERS OF COLLAGEN TYPE IV DEGRADATION IN SUBJECTS WITH METABOLIC SYNDROME
by: Edward Mekenyan, et al.
Published: (2012-12-01)

Gut microbiota induces high platelet response in patients with ST segment elevation myocardial infarction after ticagrelor treatment
by: Xi Zhang, et al.
Published: (2022-03-01)

Vorapaxar as an Alternative for Ticagrelor Resistance in Neuroendovascular Intervention
by: James C. Mamaril‐Davis, et al.
Published: (2021-11-01)

Preparation and Characterization of Novel Pharmaceutical Co-Crystals: Ticagrelor with Nicotinamide
by: Muhammad Inam, et al.
Published: (2018-08-01)

Ticagrelor Use in Indian Patients Undergoing Neuroendovascular Procedures: A Single Center Experience
by: Vivek Karan, et al.
Published: (2019-09-01)

The effect of ticagrelor on ischemia-reperfusion injury of kidney: is the pleiotropic effect a valid factor?
by: Murat BAĞCIOĞLU, et al.
Published: (2017-08-01)

Pharmacodynamic Comparison of Ticagrelor Monotherapy Versus Ticagrelor and Aspirin in Patients After Percutaneous Coronary Intervention: The TEMPLATE (Ticagrelor Monotherapy and Platelet Reactivity) Randomized Controlled Trial
by: Thomas W. Johnson, et al.
Published: (2020-12-01)

Age‐Dependent Effect of Ticagrelor Monotherapy Versus Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events: A Post Hoc Analysis of the TICO Randomized Trial
by: Byung Gyu Kim, et al.
Published: (2021-12-01)

Prolonged ventricular pause associated with ticagrelor use: A case report
by: Alaa Rahhal, et al.
Published: (2021-10-01)

Detection of calcitonin gene-related peptide based on increased antigen-driven interaction with antibody variable regions
by: Yueqing Cheng, et al.
Published: (2024-05-01)

Progress in the clinical effects and adverse reactions of ticagrelor
by: Peng Wei, et al.
Published: (2024-01-01)

Factors associated with IgG levels in adults with IgG subclass deficiency
by: James C. Barton, et al.
Published: (2021-08-01)

Assessment of myocardial salvage in patients with STEMI undergoing thrombolysis: ticagrelor versus clopidogrel
by: Stylianos Petousis, et al.
Published: (2022-07-01)

The Effect of Ticagrelor for Endovascular Intervention of Intracranial Aneurysm Patients with or without Clopidogrel Resistant: A Meta-Analysis
by: Pengfei Xia, et al.
Published: (2022-08-01)

Does the level of myocardial injury differ in primary angioplasty patients loaded first with clopidogrel and the ones with ticagrelor?
by: Nil Ozyuncu, et al.
Published: (2020-07-01)